Table 2.
Clinical characteristics and serum resistin levels of 124 hypertensive patients
| Characteristic | Number (%) | Resistin (ng/mL) | p value | |
|---|---|---|---|---|
| Sex | Male | 82 (66.1) | 7.26 (5.10–10.11) | 0.631 |
| Female | 42 (33.9) | 6.95 (5.60–11.98) | ||
| Diabetes | No | 61 (49.2) | 6.86 (5.12–10.01) | 0.472 |
| Yes | 63 (50.8) | 7.41 (5.24–10.89) | ||
| Dyslipidemia | No | 25 (20.2) | 7.23 (5.14–9.55) | 0.818 |
| Yes | 99 (79.8) | 7.18 (5.20–10.89) | ||
| ACE inhibitor | No | 80 (64.5) | 7.17 (5.14–10.81) | 0.938 |
| Yes | 44 (35.5) | 7.22 (5.26–10.16) | ||
| ARB | No | 57 (46.0) | 7.20 (4.91–10.44) | 0.833 |
| Yes | 67 (54.0) | 7.18 (5.24–10.19) | ||
| β-blocker | No | 52 (41.9) | 6.95 (5.34–9.22) | 0.491 |
| Yes | 72 (58.1) | 7.39 (4.94–11.74) | ||
| CCB | No | 68 (54.8) | 7.04 (4.67–10.16) | 0.498 |
| Yes | 56 (45.2) | 7.42 (5.40–10.79) | ||
| Statin | No | 55 (44.6) | 7.41 (5.68–10.55) | 0.260 |
| Yes | 69 (55.4) | 6.88 (4.77–10.02) | ||
| Fibrate | No | 94 (75.8) | 7.33 (5.36–10.51) | 0.253 |
| Yes | 30 (24.2) | 6.76 (4.56–8.56) | ||
| Aspirin | No | 52 (41.9) | 8.90 (5.78–10.24) | 0.525 |
| Yes | 72 (58.1) | 7.88 (4.92–10.16) | ||
| Clopidogrel | No | 94 (75.8) | 8.53 (5.36–10.17) | 0.253 |
| Yes | 30 (24.2) | 7.61 (4.56–8.56) | ||
Data are expressed as median and interquartile range after analysis by the Mann–Whitney U test
ACE angiotensin-converting enzyme, ARB angiotensin-receptor blocker, CCB calcium-channel blocker
*Values of p < 0.05 were considered statistically significant after analysis by the Mann–Whitney U test